Short answer
Indivior Pharmaceuticals, Inc. (INDV) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 8.01 (Other Events). Special Dividend triggered an adjustment to the 0.625% convertible notes due 2031.
Indivior Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Special Dividend triggered an adjustment to the 0.625% convertible notes due 2031
- Conversion rate increased from 24.0033 to 30.9355 shares per $1,000 principal
- Effective conversion price approximately $32.33 per share, increasing potential dilution
- No bondholders converted, so no immediate share issuance or dilution occurred
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Indivior Pharmaceuticals, Inc. 8-K filings
Get the next INDV 8-K as it lands
Follow INDV for push alerts, or ask the research agent what this filing means.